Alnylam Pharmaceuticals, Inc.

MORGAN STANLEY ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

970,157

Value ($000)

385,784

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	385,784	0.0%	970,157	12/31/2025
2025 Q3	11/14/2025	331,085	0.0%	726,061	9/30/2025
2025 Q2	8/14/2025	251,406	0.0%	770,968	6/30/2025
2025 Q1	5/15/2025	173,290	0.0%	641,765	3/31/2025
2024 Q4	5/15/2025	171,124	0.0%	727,224	12/31/2024
2024 Q3	5/14/2025	170,124	0.0%	618,563	9/30/2024
2024 Q2	5/14/2025	180,189	0.0%	741,514	6/30/2024
2024 Q1	5/15/2024	100,921	0.0%	675,281	3/31/2024
2023 Q4	2/13/2024	154,391	0.0%	806,595	12/31/2023
2023 Q3	11/15/2023	214,182	0.0%	1,209,383	9/30/2023
2023 Q2	8/14/2023	357,241	0.0%	1,880,806	6/30/2023
2023 Q1	5/15/2023	246,557	0.0%	1,230,815	3/31/2023
2022 Q4	2/14/2023	330,486	0.0%	1,390,640	12/31/2022
2022 Q3	11/14/2022	299,992	0.0%	1,498,759	9/30/2022
2022 Q2	10/27/2022	164,608	0.0%	1,128,615	6/30/2022
2022 Q1	10/27/2022	138,578	0.0%	848,657	3/31/2022
2021 Q4	2/14/2022	180,719	0.0%	1,065,689	12/31/2021
2021 Q3	11/15/2021	355,128	0.0%	1,880,879	9/30/2021
2021 Q2	8/23/2021	319,147	0.0%	1,882,651	6/30/2021
2021 Q1	5/17/2021	252,160	0.0%	1,785,954	3/31/2021
2020 Q4	2/16/2021	219,889	0.0%	1,691,840	12/31/2020
2020 Q3	11/13/2020	221,363	0.0%	1,520,350	9/30/2020
2020 Q2	8/14/2020	223,627	0.0%	1,509,871	6/30/2020
2020 Q1	5/26/2020	150,780	0.0%	1,385,200	3/31/2020
2019 Q4	2/14/2020	177,456	0.0%	1,540,816	12/31/2019
2014 Q1	5/13/2014	49,630	0.0%	739,186	3/31/2014
2013 Q4	2/13/2014	47,682	0.0%	741,565	12/31/2013